ARTICLE
7 August 2014

BIO Industry Group Comments On JOBS Act

MF
Morrison & Foerster LLP

Contributor

Known for providing cutting-edge legal advice on matters that are redefining industries, Morrison & Foerster has 17 offices located in the United States, Asia, and Europe. Our clients include Fortune 100 companies, leading tech and life sciences companies, and some of the largest financial institutions. We also represent investment funds and startups.
The Biotechnology Industry Organization noted that this week marks a JOBS Act milestone with the 100th company to have gone public since the Act was passed.
United States Finance and Banking

The Biotechnology Industry Organization (BIO) issued a press release (see:  http://www.biotech-now.org/events/2014/07/biotech-ceos-speak-out-on-jobs-act-success#), with the below infographic (reprinted from BIO) noted that this week marks a JOBS Act milestone with the 100th company to have gone public since the Act was passed.  The press release includes anecdotes about some recent biotech IPOs.  Biotech has been one of the most active sectors for IPOs.

Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Morrison & Foerster LLP. All rights reserved

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More